Member Info for Uncanny

And more buyers arriving

But they are buys roses if you look at the spread when reported!

What do sone know that we don’t

20mn buyer, now 25mn buyer?

20mn buyer just gone through.

Nomlungo, yes paid research but they are on a fine line to fabricate facts being FCA regulated, so they have to be factual, realistic and transparent giving all the normal disclaimers, albeit a good if not for the point that there is no research on VAL are only professional research note.

Roses, been away for a long time - has the wind blown over your stone as a hibernating animal, or has the SP increase changed things and now pumping on the negative rhetoric.

My perspective is that they are struggling for money but they have IP to sell - how good is it and what price can they command commercially?

Hello pi’s
This does not appear to be a p&d as it does not have all the normal hallmarks, otherwise we’d be back down to 0.14 yesterday IMHO.
Profit taking yesterday and understandably after a doubling in SP - traders.
We all know updates are imminent on 201 and 401 well overdue - anything else unexpected?
My gut says proceedings have moved, hopefully positively.
Financing is the key to appease the market but lots of speculation around on here, twitter, ADVFN.
Could be Monday when we hear something but certainly l hope before year end we are in a different arena.
The rhetoric from those contacting Suzy suggests - l’ll see if we can announce something - what though?
Was tempted to buy more last week but held off as l am overweight VAL as compared to my normal investment by a mile.
Respect Noise’s posts as normally more on the science perspective than trading, being connected to the industry in his own way professionally, but 10p or 12p seems a bit rich when a billion shares in issue, but would dearly love to be proved wrong!
GLA

What would a pharma pay for 55% of 401?

401 contract news must be first and then 201 update after analysis which l sincerely hope is firstly positive and secondly, before y/e to get us pack to fair value in the +£15 mn mkt range.

A proper update, with proper detail VAL please with numbers, figures and values.

I think the mm’s have stock to sell to get a flat book, inho

As above, roll on contract news - please!

Anyone know when Dr Linch is due to present his 201 findings?

Apart from couple of incidental RNS’s Jan 2019 and Oct 2018 on 401, there has not been an update since June 2018. Massively overdue IMHO.

The irony is, after the sp hurt we have suffered, if we get a similar 8.5 times bounce in the sp like we did in Dec 2017, many will sell out and it most probably will go to 2 - 5p!

Then we’ll be kicking ourselves!

One day we may have a car crash or an erectile (equivalent for our female investors) moment!

What first?

Lol Dracula

Three choices - write off / bottom drawer, cry in to your milk or try and remain positive.

I’m down on paper like many, but remain positive as despite what people say, progress is being made albeit frustratingly slow but lm not going to let this take over my life which is why l now post less.

Who knows H2H, preclinical to test in humans withe last figures showing -30% PSA reduction on 4mg dose and now continues to restrict / reduce and stop meta growth. Lets see what Dr Linch says and not highly unusual to make a deal at this juncture.

News on 401 will be led by SEEK which l would assume is before year end.

£423k in the treasury surely buys our way in to 2020 1st quarter l would guess.

GLA

The point l was making is that these same parties must have been following the progression of 201 over the last 3 years. Could it be a 201 deal or 401 update that VAL refer to as unlocking shareholder value in the near term in this weeks RNS?

https://www.proactiveinvestors.co.uk/companies/news/306581/LON:VAL/ValiRx-Plc/

GM says in talks from the top 10-12 pharmas to the smaller but mist success likely with the mid sized companies

Yes, VAL please define:

“will deliver added value in the NEAR term for our shareholders.“

I understand the cheapest bottle of wine in Brussel EU HQ is £40